Although individual survival time was likely influenced by treatments that were conducted after TACE, and causes of death were heterogeneous, the association of DKK-1 as a prognostic marker for survival of HCC patients should be further investigated. This evidence concerns the gene DKK1 and hepatocellular carcinoma.